{"@id":"https://bioecon.ru/technology/galnac-sirna-conjugates/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/galnac-sirna-conjugates/","json":"https://en.bioecon.ru/api/v1/technology/galnac-sirna-conjugates/index.json"},"id":"galnac-sirna-conjugates","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/gsk/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/bluestem-biosciences/","https://bioecon.ru/companies/global-bioenergies/","https://bioecon.ru/companies/haesin/","https://bioecon.ru/companies/puevit-gmbh/"]},"maturity":8,"name":"GalNAc-siRNA Conjugates for Hepatocyte Targeting","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Triantennary GalNAc ligand synthesis"},{"n":2,"title":"Phosphoramidite oligonucleotide synthesis"},{"n":3,"title":"Subcutaneous formulation"},{"n":4,"title":"Durable hepatic mRNA knockdown"}],"summary":"Chemically stabilized synthetic siRNA coupled to a triantennary N-acetylgalactosamine (GalNAc) ligand, targeting the asialoglycoprotein receptor (ASGPR) for subcutaneous gene silencing in hepatic diseases.","url":"/technology/galnac-sirna-conjugates/","verified":"2026-11-22"}